Phase II WHO Pre-Qualification covers both drug substance and drug product for nOPV2 at Biological E. Biological E. has already supplied 700 million doses for global stockpile and outbreak response use Integrated WHO-qualified manufacturing strengthens supply availability for cVDPV2 outbreak control Biological E. Limited (BE) today announced a